[This corrects the article DOI: 10.18632/oncotarget.2740.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609255 | PMC |
| http://dx.doi.org/10.18632/oncotarget.27038 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Corrigendum] Cripto‑1 promotes epithelial‑mesenchymal transition in prostate cancer via Wnt/β‑catenin signaling.
Oncol Rep
June 2024
Prostate Disease Laboratory, Tianjin Institute of Urology, Tianjin 300211, P.R. China.
Following the publication of the above article, an interested reader drew to the authors' attention that the β‑actin control blots featured in Figs. 5A and 6A appeared to be strikingly similar. Upon examining their original data, the authors have realized that the β‑actin blots for Fig.
View Article and Find Full Text PDFErratum to "Cripto Enhances Proliferation and Survival of Mesenchymal Stem Cells by Up-Regulating JAK2/STAT3 Pathway in a GRP78-Dependent Manner" [Biomol. Ther. 26 (2018) 464-473].
Biomol Ther (Seoul)
July 2021
Medical Science Research Institute, Soonchunhyang University, Seoul Hospital, Seoul 04401, Department of Medical Bioscience, Soonchunhyang University, Asan 31151, Republic of Korea.
Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
Oncotarget
June 2019
Inserm, U955, Equipe 7, Créteil, France.
[This corrects the article DOI: 10.18632/oncotarget.2740.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!